About US
Contact us
-
Veterans' lawsuit claims Big Pharma bribes in Iraq helped finance terrorismPharma companies have faced a gamut of allegations over the years, but a new lawsuit ups the ante by alleging several drugmakers paid bribes in Iraq that helped fuel terrorism. Filed Tuesday in2017/10/20
-
More pharma friends in high places? Ex-Lilly boss Alex Azar up for HHS chiefUntil January, Alex Azar was Eli Lilly's USA pharma chief, the company's top post in North America. Now he's reportedly in line for the top job at HHS, where he could help pharma navigate some turbu2017/10/20
-
Bristol-Myers' Opdivo gets into high gear for new melanoma approvalEarly, early, early. Bristol-Myers Squibb has been on a sprint with Opdivo in a new group of melanoma patients—with an early trial halt, a quick unveiling of detailed data, and now, a speedy review at2017/10/19
-
AstraZeneca's Lynparza ups the ante at the PARP table with FDA's speedy breast cancer reviewIn June, AstraZeneca revealed that in a phase 3 trial, its Lynparza had pared down the risk of disease worsening or death in breast cancer patients by 42%. And that showing apparently impressed the FD2017/10/19
-
With 'Dear Scientist' campaign from BG BrandLab, Pfizer keeps researchers in the spotlightLetters from patients to scientists are at the heart of a new Pfizer-sponsored contentcampaignwith the Boston Globe’s BG BrandLab. The first installment of “Dear Scientist” debuted with a letter fr2017/10/18
-
AstraZeneca lobbies for personalized asthma care with new visual snapshot toolAstraZeneca wants asthma patients to know their treatment plans should be as unique and specific to them as a fingerprint. Its solution? Lungprint. A new interactive digital tool,Lungprintallows as2017/10/18
-
Padding its lung cancer lead, Merck's Keytruda helped PD-L1 patients live 30 months longerMerck’s immuno-oncology medication Keytruda has built up an imposing lead in lung cancer, and the company is touting more positive survival data to keep that lead intact. The New Jersey drugmaker u2017/10/17
-
Outcome Health launches internal probe, offers client audits after WSJ reportOutcome Health went into crisis communications mode after a Wall Street Journalarticlelast week said the fast-growing pharma services company had misled its advertisers. Within hours, the company post2017/10/17
-
Despite notable failures, cancer vaccines are poised for a leap onto the market: expertIt's no secret that cancer vaccines have turned in multiple late-stage failures, putting a serious damper on enthusiasm in the field. But one oncology expert believes we'll see licensed cancer vacci2017/10/16
-
GlaxoSmithKline wins first-ever nod for blockbuster vaccine prospect ShingrixJust as GlaxoSmithKline nears a decision from the U.S. FDA for its key shingles vaccine, Shingrix, Canada has become the first country to approve the shot—and it's a key piece of CEO Emma Walmsley's p2017/10/16